BACKGROUND: Data on alcohol abuse as a risk factor for the development of multidrug-resistant tuberculosis (MDR-TB) are scarce. OBJECTIVE: To describe the patterns of alcohol use in MDR-TB patients and to determine whether alcohol use is associated with the development of MDR-TB in Botswana. METHODS: We compared the level of alcohol use among MDR-TB patients against three control groups: 1) non-MDR-TB patients, 2) human immunodeficiency virus (HIV) infected patients without a history of TB, and 3) the general population. Alcohol use and abuse was measured with the Alcohol Use Disorders Identification Test 10 (AUDIT) questionnaire. RESULTS: Of a total national population of 164 MDR-TB cases, 114 (70%) were interviewed. MDR-TB cases had a lifetime prevalence of alcohol use of 35.1%, which was lower than that of all control groups (P < 0.001). MDR-TB cases had higher 1-month prevalence of alcohol dependence symptoms and a lower 1-year period prevalence of alcohol dependence symptoms (P < 0.01 and P = 0.01 respectively). Among patients with TB, alcohol abuse was found to be a risk factor for the development of MDR-TB. CONCLUSION: MDR-TB patients in Botswana have high rates of alcohol use and abuse. Among TB patients, alcohol abuse is associated with the diagnosis of MDR-TB, and could be an important modifiable factor.
BACKGROUND: Data on alcohol abuse as a risk factor for the development of multidrug-resistant tuberculosis (MDR-TB) are scarce. OBJECTIVE: To describe the patterns of alcohol use in MDR-TBpatients and to determine whether alcohol use is associated with the development of MDR-TB in Botswana. METHODS: We compared the level of alcohol use among MDR-TBpatients against three control groups: 1) non-MDR-TBpatients, 2) human immunodeficiency virus (HIV) infectedpatients without a history of TB, and 3) the general population. Alcohol use and abuse was measured with the Alcohol Use Disorders Identification Test 10 (AUDIT) questionnaire. RESULTS: Of a total national population of 164 MDR-TB cases, 114 (70%) were interviewed. MDR-TB cases had a lifetime prevalence of alcohol use of 35.1%, which was lower than that of all control groups (P < 0.001). MDR-TB cases had higher 1-month prevalence of alcohol dependence symptoms and a lower 1-year period prevalence of alcohol dependence symptoms (P < 0.01 and P = 0.01 respectively). Among patients with TB, alcohol abuse was found to be a risk factor for the development of MDR-TB. CONCLUSION: MDR-TBpatients in Botswana have high rates of alcohol use and abuse. Among TBpatients, alcohol abuse is associated with the diagnosis of MDR-TB, and could be an important modifiable factor.
Authors: Elizabeth A Talbot; Thomas A Kenyon; Themba L Moeti; Gary Hsin; Laura Dooley; Shenaaz El-Halabi; Nancy J Binkin Journal: Int J STD AIDS Date: 2002-05 Impact factor: 1.359
Authors: T R Sterling; Z Zhao; A Khan; R E Chaisson; N Schluger; B Mangura; M Weiner; A Vernon Journal: Int J Tuberc Lung Dis Date: 2006-05 Impact factor: 2.373
Authors: I Y Gelmanova; S Keshavjee; V T Golubchikova; V I Berezina; A K Strelis; G V Yanova; S Atwood; M Murray Journal: Bull World Health Organ Date: 2007-09 Impact factor: 9.408
Authors: Knut Lönnroth; Brian G Williams; Stephanie Stadlin; Ernesto Jaramillo; Christopher Dye Journal: BMC Public Health Date: 2008-08-14 Impact factor: 3.295
Authors: Nicola M Zetola; Chawangwa Modongo; Patrick K Moonan; Ronald Ncube; Keikantse Matlhagela; Enoch Sepako; Ronald G Collman; Gregory P Bisson Journal: J Infect Dis Date: 2014-01-16 Impact factor: 5.226
Authors: Pamela Bachanas; Daniel Kidder; Amy Medley; Sherri L Pals; Deborah Carpenter; Andrea Howard; Gretchen Antelman; Nicolas DeLuca; Odylia Muhenje; Muhsin Sheriff; Geoffrey Somi; Frieda Katuta; Peter Cherutich; Janet Moore Journal: AIDS Behav Date: 2016-09
Authors: Puja Seth; Mary Glenshaw; Jennifer H F Sabatier; René Adams; Verona Du Preez; Nickolas DeLuca; Naomi Bock Journal: PLoS One Date: 2015-03-23 Impact factor: 3.240
Authors: Chawangwa Modongo; Rafal S Sobota; Boikobo Kesenogile; Ronald Ncube; Giorgio Sirugo; Scott M Williams; Nicola M Zetola Journal: BMC Infect Dis Date: 2014-10-09 Impact factor: 3.090